MedTrace Logo

Safety Study of Human Spinal Cord-derived Neural Stem Cell Transplantation for the Treatment of Chronic SCI

NCT01772810 · Status: UNKNOWN · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 8

Last updated 2017-09-11

No results posted yet for this study

Summary

This is a safety study of human spinal cord-derived neural stem cell (HSSC) transplantation for the treatment of chronic spinal cord injury.

Conditions

  • Spinal Cord Injury (SCI)

Interventions

DRUG

Human spinal cord stem cells.

Human spinal cord stem cell implantation in paralysis patients due to a spinal cord injury.

Sponsors & Collaborators

  • Neuralstem Inc.

    lead INDUSTRY

Principal Investigators

  • Joseph Ciacci, MD · UCSD Medical Center, Division of Neurosurgery

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-08-31
Primary Completion
2018-07-31
Completion
2022-12-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01772810 on ClinicalTrials.gov